Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Reversing extraosseous calcifications. A case of breast uremic calcific arteriolopathy.

Rodelo-Haad C, Esquivias-Motta E, Amaral-Neiva F, Martin-Malo A, Aljama P, Rodriguez M.

Breast J. 2019 Jun 11. doi: 10.1111/tbj.13389. [Epub ahead of print] No abstract available.

PMID:
31187553
2.

FGF23, Biomarker or Target?

Rodelo-Haad C, Santamaria R, Muñoz-Castañeda JR, Pendón-Ruiz de Mier MV, Martin-Malo A, Rodriguez M.

Toxins (Basel). 2019 Mar 22;11(3). pii: E175. doi: 10.3390/toxins11030175. Review.

3.

Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients.

Martin-Malo A, Borchard G, Flühmann B, Mori C, Silverberg D, Jankowska EA.

ESC Heart Fail. 2019 Apr;6(2):241-253. doi: 10.1002/ehf2.12400. Epub 2019 Jan 29. Review.

4.

Pharmacological interactions of phosphate binders.

Bover Sanjuán J, Navarro-González JF, Arenas MD, Torregrosa JV, Tamargo Menéndez J, de Francisco ALM, González-Parra E, Lloret Cora MJ, Sánchez Álvarez JE, Martín-Malo A, Molina Vila P, Bajo MA, DaSilva Santos I.

Nefrologia. 2018 Nov - Dec;38(6):573-578. doi: 10.1016/j.nefro.2018.05.003. Epub 2018 Jul 7. English, Spanish. No abstract available.

5.

Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms.

Santamaría R, Díaz-Tocados JM, Pendón-Ruiz de Mier MV, Robles A, Salmerón-Rodríguez MD, Ruiz E, Vergara N, Aguilera-Tejero E, Raya A, Ortega R, Felsenfeld A, Muñoz-Castañeda JR, Martín-Malo A, Aljama P, Rodríguez M.

Sci Rep. 2018 Sep 12;8(1):13701. doi: 10.1038/s41598-018-32065-2.

6.

Phosphate control in reducing FGF23 levels in hemodialysis patients.

Rodelo-Haad C, Rodríguez-Ortiz ME, Martin-Malo A, Pendon-Ruiz de Mier MV, Agüera ML, Muñoz-Castañeda JR, Soriano S, Caravaca F, Alvarez-Lara MA, Felsenfeld A, Aljama P, Rodriguez M.

PLoS One. 2018 Aug 7;13(8):e0201537. doi: 10.1371/journal.pone.0201537. eCollection 2018.

7.

Increased mortality in haemodialysis patients administered high doses of erythropoiesis-stimulating agents: a propensity score-matched analysis.

Pérez-García R, Varas J, Cives A, Martín-Malo A, Aljama P, Ramos R, Pascual J, Stuard S, Canaud B, Merello JI; ORD group.

Nephrol Dial Transplant. 2018 Jan 1;33(1):187. doi: 10.1093/ndt/gfx315. No abstract available.

PMID:
29077898
8.

Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.

Maduell F, Varas J, Ramos R, Martin-Malo A, Pérez-Garcia R, Berdud I, Moreso F, Canaud B, Stuard S, Gauly A, Aljama P, Merello JI.

Am J Nephrol. 2017;46(4):288-297. doi: 10.1159/000481669. Epub 2017 Oct 17.

PMID:
29041011
9.

Increased mortality in haemodialysis patients administered high doses of erythropoiesis-stimulating agents: a propensity score-matched analysis.

Pérez-García R, Varas J, Cives A, Martín-Malo A, Aljama P, Ramos R, Pascual J, Stuard S, Canaud B, Merello JI; ORD group.

Nephrol Dial Transplant. 2018 Apr 1;33(4):690-699. doi: 10.1093/ndt/gfx269.

PMID:
29036505
10.

Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach.

Varas J, Ramos R, Aljama P, Pérez-García R, Moreso F, Pinedo M, Ignacio Merello J, Stuard S, Canaud B, Martín-Malo A; ORD Group.

Nephrol Dial Transplant. 2018 Jan 1;33(1):160-170. doi: 10.1093/ndt/gfx209.

PMID:
28992120
11.

Correction of 25-OH-vitamin D deficiency improves control of secondary hyperparathyroidism and reduces the inflammation in stable haemodialysis patients.

Ojeda López R, Esquivias de Motta E, Carmona A, García Montemayor V, Berdud I, Martín Malo A, Aljama García P.

Nefrologia. 2018 Jan - Feb;38(1):41-47. doi: 10.1016/j.nefro.2017.05.008. Epub 2017 Jul 1. English, Spanish.

12.

Markers of endothelial damage in patients with chronic kidney disease on hemodialysis.

Carmona A, Agüera ML, Luna-Ruiz C, Buendía P, Calleros L, García-Jerez A, Rodríguez-Puyol M, Arias M, Arias-Guillen M, de Arriba G, Ballarin J, Bernis C, Fernández E, García-Rebollo S, Mancha J, Del Peso G, Pérez E, Poch E, Portolés JM, Rodríguez-Puyol D, Sánchez-Villanueva R, Sarro F, Torres A, Martín-Malo A, Aljama P, Ramírez R, Carracedo J.

Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F673-F681. doi: 10.1152/ajprenal.00013.2016. Epub 2017 Jan 11. Erratum in: Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F141.

13.

Hemodialysis patients receiving a greater Kt dose than recommended have reduced mortality and hospitalization risk.

Maduell F, Ramos R, Varas J, Martin-Malo A, Molina M, Pérez-Garcia R, Marcelli D, Moreso F, Aljama P, Merello JI.

Kidney Int. 2016 Dec;90(6):1332-1341. doi: 10.1016/j.kint.2016.08.022. Epub 2016 Oct 22.

14.

Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis.

Ramponi F, Ronco C, Mason G, Rettore E, Marcelli D, Martino F, Neri M, Martin-Malo A, Canaud B, Locatelli F.

Clinicoecon Outcomes Res. 2016 Sep 22;8:531-540. eCollection 2016.

15.

Hemodiafiltration With Endogenous Reinfusion Improved Microinflammation and Endothelial Damage Compared With Online-Hemodiafiltration: A Hypothesis Generating Study.

Esquivias-Motta E, Martín-Malo A, Buendia P, Álvarez-Lara MA, Soriano S, Crespo R, Carracedo J, Ramírez R, Aljama P.

Artif Organs. 2017 Jan;41(1):88-98. doi: 10.1111/aor.12704. Epub 2016 May 16.

PMID:
27182679
16.

A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease.

Rodriguez M, Salmeron MD, Martin-Malo A, Barbieri C, Mari F, Molina RI, Costa P, Aljama P.

PLoS One. 2016 Jan 25;11(1):e0146801. doi: 10.1371/journal.pone.0146801. eCollection 2016.

17.

Efficiency of Original versus Generic Intravenous Iron Formulations in Patients on Haemodialysis.

Agüera ML, Martin-Malo A, Alvarez-Lara MA, Garcia-Montemayor VE, Canton P, Soriano S, Aljama P.

PLoS One. 2015 Aug 31;10(8):e0135967. doi: 10.1371/journal.pone.0135967. eCollection 2015.

18.

Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates.

Cantisán S, Rodelo-Haad C, Páez-Vega A, Nieto A, Vaquero JM, Poyato A, Montejo M, Fariñas MC, Rivero A, Solana R, Martín-Malo A, Torre-Cisneros J.

Am J Transplant. 2015 Mar;15(3):715-22. doi: 10.1111/ajt.13012. Epub 2015 Feb 3.

19.

Hypersensitivity reactions to synthetic haemodialysis membranes — an emerging issue?

Alvarez-de Lara MA, Martín-Malo A.

Nefrologia. 2014 Nov 17;34(6):698-702. doi: 10.3265/Nefrologia.pre2014.Jul.12682. English, Spanish. No abstract available.

20.

Endothelial microparticles mediate inflammation-induced vascular calcification.

Buendía P, Montes de Oca A, Madueño JA, Merino A, Martín-Malo A, Aljama P, Ramírez R, Rodríguez M, Carracedo J.

FASEB J. 2015 Jan;29(1):173-81. doi: 10.1096/fj.14-249706. Epub 2014 Oct 23.

PMID:
25342130
21.

Endothelial damage and vascular calcification in patients with chronic kidney disease.

Soriano S, Carmona A, Triviño F, Rodriguez M, Alvarez-Benito M, Martín-Malo A, Alvarez-Lara MA, Ramírez R, Aljama P, Carracedo J.

Am J Physiol Renal Physiol. 2014 Dec 1;307(11):F1302-11. doi: 10.1152/ajprenal.00114.2014. Epub 2014 Oct 22.

22.

Klotho Prevents NFκB Translocation and Protects Endothelial Cell From Senescence Induced by Uremia.

Buendía P, Carracedo J, Soriano S, Madueño JA, Ortiz A, Martín-Malo A, Aljama P, Ramírez R.

J Gerontol A Biol Sci Med Sci. 2015 Oct;70(10):1198-209. doi: 10.1093/gerona/glu170. Epub 2014 Sep 22.

PMID:
25246106
23.

Effectiveness of haemodiafiltration with ultrafiltrate regeneration in the reduction of light chains in multiple myeloma with renal failure.

Pendón-Ruiz de Mier MV, Alvarez-Lara MA, Ojeda-López R, Martín-Malo A, Carracedo J, Caballero-Villarraso J, Alonso C, Aljama P.

Nefrologia. 2013 Nov 13;33(6):788-96. doi: 10.3265/Nefrologia.pre2013.Sep.12176. English, Spanish.

24.

Compliance with mineral metabolism targets in haemodialysis patients: moving backwards?

Palomares I, Ramos R, Martin-Malo A, Merello JI, Praga M, Luño J, de Francisco AL; ORD Group.

Blood Purif. 2013;36(2):122-31. doi: 10.1159/000353418. Epub 2013 Nov 5.

PMID:
24217176
25.

Impact of targeting Kt instead of Kt/V.

Maduell F, Ramos R, Palomares I, Martín-Malo A, Molina M, Bustamante J, Pérez-García R, Grassmann A, Merello JI; ORD Group.

Nephrol Dial Transplant. 2013 Oct;28(10):2595-603. doi: 10.1093/ndt/gft255.

PMID:
24078643
26.

Activation of vitamin D receptors in the optimization of hyperparathyroidism secondary to dialysis.

Herrero JA, López-Gómez JM, Maduell F, Martín-de Francisco ÁL, Martín-Malo A, Martínez-Castelao A, Navarro-González JF, Pérez-Fontán M, Pérez J, Selgas R, Solozabal C.

Nefrologia. 2013;33(4):571-84. doi: 10.3265/Nefrologia.pre2013.May.11901. Review. English, Spanish. No abstract available.

27.

New alternatives in the treatment of myeloma kidney.

Álvarez-Lara MA, Martín-Malo A, Aljama-García P.

Nefrologia. 2013;33(4):443-7. doi: 10.3265/Nefrologia.pre2013.Jun.12138. English, Spanish. No abstract available.

28.

Effectiveness of haemodiafiltration with ultrafiltrate regeneration in renal failure due to multiple myeloma.

Pendón-Ruiz de Mier MV, Ojeda-López R, Alvarez de Lara-Sánchez MA, Martín-Malo A, Aljama-García P.

Nefrologia. 2013;33(3):426-8. doi: 10.3265/Nefrologia.pre2013.Feb.11892. English, Spanish. No abstract available.

29.

Post-dilution high convective transport improves microinflammation and endothelial dysfunction independently of the technique.

Ariza F, Merino A, Carracedo J, Alvarez de Lara MA, Crespo R, Ramirez R, Martín-Malo A, Aljama P.

Blood Purif. 2013;35(4):270-8. doi: 10.1159/000350611. Epub 2013 May 8.

PMID:
23689471
30.

Cellular senescence determines endothelial cell damage induced by uremia.

Carracedo J, Buendía P, Merino A, Soriano S, Esquivias E, Martín-Malo A, Aljama P, Ramírez R.

Exp Gerontol. 2013 Aug;48(8):766-73. doi: 10.1016/j.exger.2013.04.004. Epub 2013 Apr 25.

PMID:
23624226
31.

The relationship of NT-proBNP and dialysis parameters with outcome of incident haemodialysis patients: results from the membrane permeability outcome study.

Locatelli F, Hannedouche T, Martin-Malo A, Jacobson SH, Vanholder R, Ronco C, La Milia V, Lopez Gomez JM, Stefoni S, Maheut H, Klinger M, Krummel T, Dhondt A, Berdud I, Gauly A.

Blood Purif. 2013;35(1-3):216-23. doi: 10.1159/000347076. Epub 2013 Mar 28.

32.

The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients.

Soriano S, Ojeda R, Rodríguez M, Almadén Y, Rodríguez M, Martín-Malo A, Aljama P.

Clin Nephrol. 2013 Jul;80(1):17-22. doi: 10.5414/CN107764.

PMID:
23391319
33.

Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD® database: results from years 2009-2010.

Pérez-García R, Palomares-Sancho I, Merello-Godino JI, Aljama-García P, Bustamante-Bustamante J, Luño J, Maduell-Canals F, Martín-de Francisco AL, Martín-Malo A, Mirapeix-i-Vicens E, Molina-Núñez M, Praga-Terente M, Tetta C, Marcelli D; Grupo ORD (Optimizando Resultados de Diálisis).

Nefrologia. 2012;32(6):743-53. doi: 10.3265/Nefrologia.pre2012.Jul.11549. English, Spanish.

34.

Klotho modulates the stress response in human senescent endothelial cells.

Carracedo J, Buendía P, Merino A, Madueño JA, Peralbo E, Ortiz A, Martín-Malo A, Aljama P, Rodríguez M, Ramírez R.

Mech Ageing Dev. 2012 Nov-Dec;133(11-12):647-54. doi: 10.1016/j.mad.2012.09.002. Epub 2012 Sep 21.

PMID:
23000105
35.

Geographical variability of patient characteristics and treatment patterns affect outcomes for incident hemodialysis patients.

Martin-Malo A, Papadimitriou M, Cruz J, Bustamante J, Verbeelen D, Nony A, Vanholder R, Jacobson SH, Montenegro J, Hannedouche T, Wizemann V, Locatelli F; Membrane Permeability Outcome (MPO) Study Group.

J Nephrol. 2013 Jan-Feb;26(1):119-28. doi: 10.5301/jn.5000116.

PMID:
22476964
36.

Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients.

Merino A, Alvarez-Lara MA, Ramirez R, Carracedo J, Martin-Malo A, Aljama P.

Nephrol Dial Transplant. 2012 Jul;27(7):2907-12. doi: 10.1093/ndt/gfr767. Epub 2012 Jan 13.

PMID:
22247233
37.

Effects of intravenous iron on mononuclear cells during the haemodialysis session.

Martin-Malo A, Merino A, Carracedo J, Alvarez-Lara MA, Ojeda R, Soriano S, Crespo R, Ramirez R, Aljama P.

Nephrol Dial Transplant. 2012 Jun;27(6):2465-71. doi: 10.1093/ndt/gfr711. Epub 2011 Dec 29.

PMID:
22207322
38.

Evolution of the concept of biocompatibility and the cardioprotective effect of on-line hemodiafiltration.

Ramírez R, Martín-Malo A, Aljama P.

Contrib Nephrol. 2011;175:110-116. doi: 10.1159/000333294. Epub 2011 Dec 15.

PMID:
22188693
39.

Risk factors associated with cardiovascular morbidity and mortality in Spanish incident hemodialysis patients: two-year results from the ANSWER study.

Cuevas X, García F, Martín-Malo A, Fort J, Lladós F, Lozano J, Pérez-García R.

Blood Purif. 2012;33(1-3):21-9. doi: 10.1159/000332395. Epub 2011 Nov 30.

40.

Tandem plasmapheresis and hemodialysis: efficacy and safety.

Pérez-Sáez MJ, Toledo K, Ojeda R, Crespo R, Soriano S, Alvarez de Lara MA, Martín-Malo A, Aljama P.

Ren Fail. 2011;33(8):765-9. doi: 10.3109/0886022X.2011.599912. Epub 2011 Jul 20.

PMID:
21770855
41.

Renal function after dopamine and fluid administration in patients with malignant obstructive jaundice. A prospective randomized study.

Naranjo A, Cruz A, López P, Chicano M, Martín-Malo A, Sitges-Serra A, Muntané J, Padillo J.

J Gastrointestin Liver Dis. 2011 Jun;20(2):161-7.

42.

CD14+CD16+ monocytes from chronic kidney disease patients exhibit increased adhesion ability to endothelial cells.

Ramírez R, Carracedo J, Merino A, Soriano S, Ojeda R, Alvarez-Lara MA, Martín-Malo A, Aljama P.

Contrib Nephrol. 2011;171:57-61. doi: 10.1159/000327134. Epub 2011 May 23. Review.

PMID:
21625090
43.

Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.).

Torregrosa JV, Bover J, Cannata Andía J, Lorenzo V, de Francisco AL, Martínez I, Rodríguez Portillo M, Arenas L, González Parra E, Caravaca F, Martín-Malo A, Fernández Giráldez E, Torres A; Spanish Nephrology Society.

Nefrologia. 2011;31 Suppl 1:3-32. doi: 10.3265/Nefrologia.pre2011.Jan.10816. No abstract available. Erratum in: Nefrologia. 2011 Mar 22;31(2): following 240.

44.

Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells.

Carracedo J, Merino A, Briceño C, Soriano S, Buendía P, Calleros L, Rodriguez M, Martín-Malo A, Aljama P, Ramírez R.

FASEB J. 2011 Apr;25(4):1314-22. doi: 10.1096/fj.10-173377. Epub 2011 Jan 12.

PMID:
21228221
45.

Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity.

Merino A, Buendia P, Martin-Malo A, Aljama P, Ramirez R, Carracedo J.

J Immunol. 2011 Feb 1;186(3):1809-15. doi: 10.4049/jimmunol.1001866. Epub 2010 Dec 29.

46.

Darbepoetin-α treatment enhances glomerular regenerative process in the Thy-1 glomerulonephritis model.

Cañadillas S, Ortega R, Estepa JC, Egea J, Gonzalez-Menchen A, Perez-Seoane C, Lopez-Andreu M, Ramirez R, Tetta C, Rodriguez M, Martin-Malo A, Aljama P.

Am J Physiol Renal Physiol. 2010 Dec;299(6):F1278-87. doi: 10.1152/ajprenal.00343.2009. Epub 2010 Sep 8.

47.

Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study.

Fort J, Cuevas X, García F, Pérez-García R, Lladós F, Lozano J, Martín-Malo A; ANSWER study.

Nephrol Dial Transplant. 2010 Aug;25(8):2702-10. doi: 10.1093/ndt/gfq073. Epub 2010 Feb 22.

PMID:
20176608
48.

Effect of different dialysis modalities on microinflammatory status and endothelial damage.

Merino A, Portolés J, Selgas R, Ojeda R, Buendia P, Ocaña J, Bajo MA, del Peso G, Carracedo J, Ramírez R, Martín-Malo A, Aljama P.

Clin J Am Soc Nephrol. 2010 Feb;5(2):227-34. doi: 10.2215/CJN.03260509. Epub 2010 Jan 7.

49.

Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis.

Ramirez R, Carracedo J, Nogueras S, Buendia P, Merino A, Cañadillas S, Rodríguez M, Tetta C, Martin-Malo A, Aljama P.

J Mol Cell Cardiol. 2009 Dec;47(6):781-8. doi: 10.1016/j.yjmcc.2009.09.005. Epub 2009 Sep 24.

PMID:
19782086
50.

[Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance].

Coll E, Pérez-García R, Martín de Francisco AL, Galcerán J, García-Osuna R, Martín-Malo A, Martínez-Castelao A, Sánchez B, Llopis R, Alvarez de Lara MA.

Nefrologia. 2009;29(2):156-62. doi: 10.3265/Nefrologia.2009.29.2.4969.en.full. Spanish.

Supplemental Content

Loading ...
Support Center